Identification of pyrazolo[1,5-a]pyrimidine-3-carboxylates as B-Raf kinase inhibitors. 2009

Ariamala Gopalsamy, and Greg Ciszewski, and Yongbo Hu, and Frederick Lee, and Larry Feldberg, and Eileen Frommer, and Steven Kim, and Karen Collins, and Donald Wojciechowicz, and Robert Mallon
Chemical and Screening Sciences, Wyeth Research, Pearl River, NY 10965, USA. gopalsa@wyeth.com

B-Raf kinase plays a critical role in the Raf-MEK-ERK signaling pathway and inhibitors of B-Raf could be used in the treatment of melanomas, colorectal cancer, and other Ras related human cancers. We have identified novel small molecule pyrazolo[1,5-a]pyrimidine derivatives as B-Raf kinase inhibitors. Structure-activity relationship was generated for various regions of the scaffold to improve the biochemical profile.

UI MeSH Term Description Entries
D011743 Pyrimidines A family of 6-membered heterocyclic compounds occurring in nature in a wide variety of forms. They include several nucleic acid constituents (CYTOSINE; THYMINE; and URACIL) and form the basic structure of the barbiturates.
D003198 Computer Simulation Computer-based representation of physical systems and phenomena such as chemical processes. Computational Modeling,Computational Modelling,Computer Models,In silico Modeling,In silico Models,In silico Simulation,Models, Computer,Computerized Models,Computer Model,Computer Simulations,Computerized Model,In silico Model,Model, Computer,Model, Computerized,Model, In silico,Modeling, Computational,Modeling, In silico,Modelling, Computational,Simulation, Computer,Simulation, In silico,Simulations, Computer
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D013329 Structure-Activity Relationship The relationship between the chemical structure of a compound and its biological or pharmacological activity. Compounds are often classed together because they have structural characteristics in common including shape, size, stereochemical arrangement, and distribution of functional groups. Relationship, Structure-Activity,Relationships, Structure-Activity,Structure Activity Relationship,Structure-Activity Relationships
D045744 Cell Line, Tumor A cell line derived from cultured tumor cells. Tumor Cell Line,Cell Lines, Tumor,Line, Tumor Cell,Lines, Tumor Cell,Tumor Cell Lines
D047428 Protein Kinase Inhibitors Agents that inhibit PROTEIN KINASES. Protein Kinase Inhibitor,Inhibitor, Protein Kinase,Inhibitors, Protein Kinase,Kinase Inhibitor, Protein,Kinase Inhibitors, Protein
D048493 Proto-Oncogene Proteins B-raf A raf kinase subclass found at high levels in neuronal tissue. The B-raf Kinases are MAP kinase kinase kinases that have specificity for MAP KINASE KINASE 1 and MAP KINASE KINASE 2. B-raf Kinase,BRAF Kinase,B-raf Kinases,BRAF Kinases,Proto-Oncogene Protein B-raf,B raf Kinase,B raf Kinases,B-raf, Proto-Oncogene Protein,B-raf, Proto-Oncogene Proteins,Kinase, B-raf,Kinase, BRAF,Protein B-raf, Proto-Oncogene,Proteins B-raf, Proto-Oncogene,Proto Oncogene Protein B raf,Proto Oncogene Proteins B raf

Related Publications

Ariamala Gopalsamy, and Greg Ciszewski, and Yongbo Hu, and Frederick Lee, and Larry Feldberg, and Eileen Frommer, and Steven Kim, and Karen Collins, and Donald Wojciechowicz, and Robert Mallon
January 2012, Bioorganic & medicinal chemistry letters,
Ariamala Gopalsamy, and Greg Ciszewski, and Yongbo Hu, and Frederick Lee, and Larry Feldberg, and Eileen Frommer, and Steven Kim, and Karen Collins, and Donald Wojciechowicz, and Robert Mallon
October 2008, Bioorganic & medicinal chemistry letters,
Ariamala Gopalsamy, and Greg Ciszewski, and Yongbo Hu, and Frederick Lee, and Larry Feldberg, and Eileen Frommer, and Steven Kim, and Karen Collins, and Donald Wojciechowicz, and Robert Mallon
October 2005, Organic letters,
Ariamala Gopalsamy, and Greg Ciszewski, and Yongbo Hu, and Frederick Lee, and Larry Feldberg, and Eileen Frommer, and Steven Kim, and Karen Collins, and Donald Wojciechowicz, and Robert Mallon
November 2009, Bioorganic & medicinal chemistry letters,
Ariamala Gopalsamy, and Greg Ciszewski, and Yongbo Hu, and Frederick Lee, and Larry Feldberg, and Eileen Frommer, and Steven Kim, and Karen Collins, and Donald Wojciechowicz, and Robert Mallon
November 2018, Cell chemical biology,
Ariamala Gopalsamy, and Greg Ciszewski, and Yongbo Hu, and Frederick Lee, and Larry Feldberg, and Eileen Frommer, and Steven Kim, and Karen Collins, and Donald Wojciechowicz, and Robert Mallon
November 2008, Bioorganic & medicinal chemistry letters,
Ariamala Gopalsamy, and Greg Ciszewski, and Yongbo Hu, and Frederick Lee, and Larry Feldberg, and Eileen Frommer, and Steven Kim, and Karen Collins, and Donald Wojciechowicz, and Robert Mallon
September 2012, Acta crystallographica. Section E, Structure reports online,
Ariamala Gopalsamy, and Greg Ciszewski, and Yongbo Hu, and Frederick Lee, and Larry Feldberg, and Eileen Frommer, and Steven Kim, and Karen Collins, and Donald Wojciechowicz, and Robert Mallon
January 2012, Bioorganic & medicinal chemistry,
Ariamala Gopalsamy, and Greg Ciszewski, and Yongbo Hu, and Frederick Lee, and Larry Feldberg, and Eileen Frommer, and Steven Kim, and Karen Collins, and Donald Wojciechowicz, and Robert Mallon
November 2013, Molecular diversity,
Ariamala Gopalsamy, and Greg Ciszewski, and Yongbo Hu, and Frederick Lee, and Larry Feldberg, and Eileen Frommer, and Steven Kim, and Karen Collins, and Donald Wojciechowicz, and Robert Mallon
January 1978, Il Farmaco; edizione scientifica,
Copied contents to your clipboard!